BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8058313)

  • 1. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
    Hahn SL; Wasylyk B
    Oncogene; 1994 Sep; 9(9):2499-512. PubMed ID: 8058313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
    Schmidt M; Schmidt AM; Dietl J; Kammerer U
    Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic conversion alters the transcriptional properties of ets.
    Wasylyk C; Wasylyk B
    Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene.
    Reddy ES; Rao VN
    Cancer Res; 1990 Aug; 50(16):5013-6. PubMed ID: 2165853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM; Wurtz JM; Wasylyk B
    EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
    Leprince D; Crepieux P; Stehelin D
    Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1.
    Leprince D; Crepieux P; Laudet V; Flourens A; Stehelin D
    Virology; 1993 Jun; 194(2):855-7. PubMed ID: 8389086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.
    Hodge DR; Robinson L; Watson D; Lautenberger J; Zhang XK; Venanzoni M; Seth A
    Oncogene; 1996 Jan; 12(1):11-8. PubMed ID: 8552380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional dissection of the transcription factor Elk-1.
    Janknecht R; Zinck R; Ernst WH; Nordheim A
    Oncogene; 1994 Apr; 9(4):1273-8. PubMed ID: 8134131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
    Garrido C; Leprince D; Plaza S; Aumercier M; Stéhelin D; Saule S
    Oncogene; 1996 Apr; 12(7):1449-56. PubMed ID: 8622861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When Ets transcription factors meet their partners.
    Verger A; Duterque-Coquillaud M
    Bioessays; 2002 Apr; 24(4):362-70. PubMed ID: 11948622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets oncogene family.
    Dhulipal PD
    Indian J Exp Biol; 1997 Apr; 35(4):315-22. PubMed ID: 9315229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
    Reddy ES; Rao VN
    Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family.
    Schneikert J; Lutz Y; Wasylyk B
    Oncogene; 1992 Feb; 7(2):249-56. PubMed ID: 1549346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.